• University of Pennsylvania Featured PhD Programmes
  • Staffordshire University Featured PhD Programmes
  • University of Tasmania Featured PhD Programmes
  • FindA University Ltd Featured PhD Programmes
  • University of Leeds Featured PhD Programmes
  • University of Cambridge Featured PhD Programmes
  • Aberdeen University Featured PhD Programmes
University of Liverpool Featured PhD Programmes
Imperial College London Featured PhD Programmes
Coventry University Featured PhD Programmes
Peter MacCallum Cancer Centre Featured PhD Programmes
University of Tasmania Featured PhD Programmes

Development of a new class of anti-bacterial agents for the treatment of MR-bacteria

  • Full or part time
    Dr Jonathan Sellars
  • Application Deadline
    Applications accepted all year round
  • Self-Funded PhD Students Only
    Self-Funded PhD Students Only

Project Description

Applications are invited from Graduates in Chemistry, Pharmacy and Medicinal Chemistry Master’s level programs to join our group within the School of Medicine, Pharmacy and Health. The project encompasses the synthesis and biological screening of a novel group of new anti-bacterial agents for the treatment of MRSA and other multi-resistant bacteria.

No new class of antibiotics have been developed and brought to market in the past 25 years. This has been brought about by the low cost of the drugs when brought to market and a lack of longevity due to the rapid onset of resistance. Nevertheless, governments and other organizations around the world are now beginning to address this issue, with new funding and regulation to aid the search for new antibiotics to avert a potential antibiotic apocalypse when common infections could become deadly.( https://www.gov.uk/government/news/prime-minister-warns-of-global-threat-of-antibiotic-resistance; http://www.rsc.org/chemistryworld/2014/07/call-new-models-pay-antibiotics-resistance-drug-pharmaceutical-companies; http://www.rsc.org/chemistryworld/2015/01/12-billion-dollar-package-unveiled-fight-antibiotic-resistance-obama

To address this, our project will involve the following a. combinatorial synthesis and expansion of a library of diverse structural analogues of an existing compound demonstrating excellent antibacterial activity; b. iterative testing of the compound library will be undertaken in house with our biology partners to elucidate the biological activity and aid the design of more potent analogues. All this will be undertaken in our world leading facilities here at Durham, where you will have access to state of the art laboratories and analytical equipment.

Potential candidates will require a strong background in chemical synthesis, with a background knowledge of microbiological techniques and protein purification advantageous.

Successful candidates will be encouraged to participate in national and international conferences on antibacterial resistance. The project/candidate will be actively involved in the Wolfson Special Interest Group “Filling the Void – the search for new antimicrobial targets and inhibitors” (https://www.dur.ac.uk/wolfson.institute/sig/void/).

Funding Notes

PLEASE NOTE THAT THIS IS FOR SELF-FUNDED STUDENTS ONLY.

For project information please contact the lead supervisor. For all other enquiries please contact the Research Student Administrator.

References

Please check that you meet our entry requirements. See our website https://www.dur.ac.uk/school.health/research/degrees/entry/ for information.

Email Now

Insert previous message below for editing? 
You haven’t included a message. Providing a specific message means universities will take your enquiry more seriously and helps them provide the information you need.
Why not add a message here
* required field
Send a copy to me for my own records.
Email Sent

Share this page:

Cookie Policy    X